Sorrento Therapeutics, Inc.'s Form 4 filing
Scilex Holding Co (SCLX) · filed Nov 23, 2022
- Accession no.
- 0000899243-22-036956
- Filed
- Nov 23, 2022, 5:59 PM ET
- Trade date
- Nov 23, 2022
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 0 non-derivative transactions and 1 derivative transaction. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sorrento Therapeutics, Inc.CIK 0000850261 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 23, 2022 | Common Stock | PPurchaseAcquired | +442,829 | $0.3967 | +$175,670.26 | 4,219,604 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.